Nectar RHS Komplementar ApS: Financial statements 2025
CVR: 41934530
Nectar RHS Komplementar ApS (CVR 41934530) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -5,000 and a net result of DKK 38,849 compared with DKK 58,075 the year before. Equity amounted to DKK 177,416. The solvency ratio was 82.3%. The company had 1 employee in the financial year.
- Gross Profit
- -5,000 kr.
- Profit/Loss
- 38,849 kr.
- Equity
- 177,416 kr.
- Total Assets
- 215,688 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -5 t. | 39 t. | 177 t. | 1 |
| 2024 | - | -5 t. | 58 t. | 139 t. | 1 |
| 2023 | - | -5 t. | 15 t. | 80 t. | 1 |
| 2022 | - | -13 t. | 10 t. | 65 t. | 0 |
| 2021 | - | -5 t. | 16 t. | 56 t. | 0 |
Find more companies like Nectar RHS Komplementar ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
Nectar RHS Komplementar ApS has published its annual report for 2024. Gross profit came to DKK -5,000, and the net result was DKK 58,075.
About Nectar RHS Komplementar ApS
Nectar RHS Komplementar ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Bjørk Krogshave. The company is owned by PharmaService I/S and Nectar Invest A/S. In 2025, the company reported a gross profit of DKK -5,000 and a net result of DKK 38,849 compared with DKK 58,075 the year before. Equity amounted to DKK 177,416.
